{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VTRLY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTRLY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTRLY\",,,,,undefined,":{"symbol":"VTRLY","market":"US","secType":"STK","nameCN":"Vitrolife AB","latestPrice":9.5,"timestamp":1772226000000,"preClose":9.5,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":135000000,"shares":135000000,"eps":-0.661818,"marketStatus":"Market Closed","change":0,"latestTime":"02-27 16:00:00 EST Delay","open":9.5,"high":9.5,"low":9.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.661818,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":9.5,"volumeRatio":0.9701485297399032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTRLY\",,,,,undefined,":{"symbol":"VTRLY","floatShares":135000000,"roa":"-21.15%","roe":"-46.55%","lyrEps":-0.707062,"volumeRatio":0.9701485297399032,"shares":135000000,"dividePrice":0.1193,"high":9.5,"amplitude":0,"preClose":9.5,"low":9.5,"week52Low":9.5,"pbRate":"1.47","psRate":"3.37","week52High":18.5499,"institutionHeld":0,"latestPrice":9.5,"eps":-0.661818,"divideRate":0.012558,"volume":0,"delay":15,"ttmEps":-0.661818,"open":9.5,"prevYearClose":15.065,"prevWeekClose":9.5,"prevMonthClose":15.3,"prevQuarterClose":15.065,"fiveDayClose":9.5,"twentyDayClose":15.3,"sixtyDayClose":15.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTRLY\",params:#limit:5,,,undefined,":[{"date":"2026-05-07","symbol":"VTRLY","amount":0.072725,"announcedDate":"2026-02-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-07","defaultRemindTime":1778160600000,"name":"Vitrolife AB","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-05-07","currency":"USD","dateTimestamp":1778126400000,"payDate":"2026-05-27"},{"date":"2025-05-02","symbol":"VTRLY","amount":0.09953,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-02","defaultRemindTime":1746192600000,"name":"Vitrolife AB","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-21","payableDate":"2025-05-02","currency":"USD","dateTimestamp":1746158400000,"payDate":"2025-05-21"},{"date":"2024-07-17","symbol":"VTRLY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721203200000,"name":null,"time":"","dateTimestamp":1721188800000,"actualEps":null},{"date":"2024-04-26","symbol":"VTRLY","amount":0.09531,"announcedDate":"2024-02-02","type":"dividend","market":"US","newRecordDate":"2024-04-29","defaultRemindTime":1714138200000,"name":"Vitrolife AB","recordDate":"2024-05-17","payableDate":"2024-04-29","currency":"USD","dateTimestamp":1714104000000,"payDate":"2024-05-17"},{"market":"US","date":"2024-04-18","symbol":"VTRLY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1713412800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTRLY\",market:\"US\",,,undefined,":[{"executeDate":"2021-04-29","recordDate":"2021-04-30","paymentDate":"2021-05-16","value":0.057698,"currency":"USD"},{"executeDate":"2022-04-28","recordDate":"2022-04-29","paymentDate":"2022-05-18","value":0.086352,"currency":"USD"},{"executeDate":"2023-05-01","recordDate":"2023-05-02","paymentDate":"2023-05-19","value":0.082074,"currency":"USD"},{"executeDate":"2024-04-26","recordDate":"2024-04-29","paymentDate":"2024-05-17","value":0.09531,"currency":"USD"},{"executeDate":"2025-05-02","recordDate":"2025-05-02","paymentDate":"2025-05-21","value":0.09953,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTRLY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1738299600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTRLY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608921840","title":"Press Release: Vitrolife AB (publ) - Fourth quarter and full year report 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2608921840","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608921840?lang=en_us&edition=fundamental","pubTime":"2026-02-03 15:26","pubTimestamp":1770103560,"startTime":"0","endTime":"0","summary":"-- Sales of SEK 891  million, organic growth in local currencies. excluding discontinued business* were 6%, 3% growth in local currencies. and 7% decrease in SEK, due to a significant currency impact of -10%.-- Sales per region, in local currencies, were -1% in EMEA excluding. discontinued business, +9% in Americas and +10% in APAC.-- Sales per product group, in local currencies excluding discontinued. business, were +10% in Consumables, +6% in Technologies and +1% in. -- Gross margin decreased to 58.0% . Gross margin excluding. -- Earnings before depreciation and amortisation  amounted to SEK. excluding restructuring costs amounted to SEK 251  million,resulting in an EBITDA margin of 28.2%  impacted by negative. -- Restructuring costs of SEK 55 million whereof SEK 6 million in COGS and. -- An impairment charge of SEK 5,357 million was reported as other operating. charge and restructuring costs amounted to SEK 89 million ,resulting in earnings per share of SEK 0.66 .-- Sales of SEK 3,4","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4139","BK4598","LU0128526141.USD","BK4135","VTRLY","LU0029874061.USD","AB"],"gpt_icon":0},{"id":"2579924045","title":"Press Release: Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2579924045","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579924045?lang=en_us&edition=fundamental","pubTime":"2025-10-29 16:26","pubTimestamp":1761726360,"startTime":"0","endTime":"0","summary":"GOTHENBURG, Sweden, Oct. 29, 2025 /PRNewswire/ -- In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2025, the members who, together with the Chair of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2026 have been elected.Niels Jacobsen, appointed by William Demant Invest A/S. Patricia Hedelius, appointed by AMF Fonder & Pension. The Annual General Meeting of Vitrolife AB will be held in Gothenburg on 6 May 2026.Shareholders who wish to submit proposals to the Nomination Committee may contact the Chair of the Board of Vitrolife AB on e-mail: investors@vitrolife.com.Amelie Wilson, Investor relations, external corporate communications and executive support, awilson@vitrolife.com. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","AB","BK4139","VTRLY","BK4590","LU0029874061.USD","BK4135","BK4598"],"gpt_icon":0},{"id":"2577232772","title":"Press Release: Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas","url":"https://stock-news.laohu8.com/highlight/detail?id=2577232772","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577232772?lang=en_us&edition=fundamental","pubTime":"2025-10-23 14:38","pubTimestamp":1761201480,"startTime":"0","endTime":"0","summary":"-- Sales of SEK 835  million, 3% growth in local currencies and a 4%. decrease in SEK, due to a significant currency impact of -7%. Organic. growth in local currencies excluding discontinued business* was 5%.-- Sales per region, in local currencies, were -2% in EMEA, +4% excluding. discontinued business, +11% in Americas and +1% in APAC.business, were +7 in Consumables, +8% in Technologies and +3% in. -- Sales per product group, in local currencies, were +4% in Consumables,-- Gross margin increased to 58.9% , explained by a favourable product. -- Earnings before depreciation and amortisation  amounted to SEK. 253  million, resulting in an EBITDA margin of 30.3% ,-- Operating cash flow amounted to SEK 255  million.-- Net income amounted to SEK 102  million, resulting in earnings per. -- Sales of SEK 2,548  million, 1% growth in local currencies and a. -- Sales per region, in local currencies, were +1% in EMEA, +8% excluding. discontinued business, +8% in Americas and -5% in APAC.Amelie ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4135","BK4139","LU0128526141.USD","VTRLY","BK4598","BK4590","AB"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VTRLY\",params:#limit:6,delay:false,,,undefined,":[]}}